The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistanceTomislav Kostyanev, Herman Goossens, Marc J. M. Bonten et al.|Journal of Antimicrobial Chemotherapy|2015Cited by 129
Bacterial type I signal peptidase inhibitors - Optimized hits from natureNatalia Szałaj, Anna Więckowska, Sherry L. Mowbray et al.|European Journal of Medicinal Chemistry|2022Cited by 18